1. Home
  2. TROO vs GOSS Comparison

TROO vs GOSS Comparison

Compare TROO & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TROOPS Inc.

TROO

TROOPS Inc.

N/A

Current Price

$1.89

Market Cap

151.5M

Sector

Technology

ML Signal

N/A

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$3.57

Market Cap

726.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TROO
GOSS
Founded
2005
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.5M
726.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TROO
GOSS
Price
$1.89
$3.57
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.60
AVG Volume (30 Days)
67.8K
3.2M
Earning Date
12-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,084,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.41
P/E Ratio
N/A
N/A
Revenue Growth
247.24
N/A
52 Week Low
$0.49
$0.76
52 Week High
$2.62
$3.87

Technical Indicators

Market Signals
Indicator
TROO
GOSS
Relative Strength Index (RSI) 76.51 61.72
Support Level $1.54 $3.53
Resistance Level $1.75 $3.87
Average True Range (ATR) 0.18 0.23
MACD 0.05 0.00
Stochastic Oscillator 88.54 64.80

Price Performance

Historical Comparison
TROO
GOSS

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: